TaiGen Biopharmaceuticals Holdings Limited(TW:4157)
NT$8.29+0.17 (+2.09%)
TW:4157
TaiGen Biopharmaceuticals Holdings Limited Revenue
NT$8.29
At close:+0.17 (+2.09%)
TaiGen Biopharmaceuticals Holdings Limited (4157) Revenue
TaiGen Biopharmaceuticals Holdings Limited Revenue
TaiGen Biopharmaceuticals Holdings Limited had a revenue of 8.23M in the quarter ending Jun 30, 2026, with -20.44%. This bring the company's revenue in the last twelve months to 256.46M, Decreased 0.96%. In the fiscal year ending Dec 31, 2025, TaiGen Biopharmaceuticals Holdings Limited had annual revenue of 259.47M with 72.24% growth.
- Revenue (ttm)
- 256.46M
- Revenue Growth
- 530.40%
- P/S Ratio
- 22.28
- Revenue/Employee
- TWD 4,989,885
- Employees
- 52
- Market Cap
- TWD 5.78B
Revenue Chart
TaiGen Biopharmaceuticals Holdings Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 259.47M | 108.82M | 72.24% |
| Dec 31, 2024 | 150.65M | 27.52M | 22.35% |
| Dec 31, 2023 | 123.13M | 86.90M | 239.87% |
| Dec 31, 2022 | 36.23M | -1.26B | -97.20% |
| Dec 31, 2021 | 1.29B | 1.27B | 5426.95% |
| Dec 31, 2020 | 23.42M | 3.11M | 15.30% |
| Dec 31, 2019 | 20.31M | -9.30M | -31.41% |
| Dec 31, 2018 | 29.62M | -523.59M | -94.65% |
| Dec 31, 2017 | 553.21M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.